Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
18.87
-0.33 (-1.72%)
At close: Mar 6, 2026, 4:00 PM EST
18.85
-0.02 (-0.11%)
After-hours: Mar 6, 2026, 4:10 PM EST
Sanara MedTech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sanara MedTech stock have an average target of 41, with a low estimate of 36 and a high estimate of 46. The average target predicts an increase of 117.28% from the current stock price of 18.87.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 26, 2026.
Analyst Ratings
The average analyst rating for Sanara MedTech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +90.78% | Jan 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $54 → $36 | Strong Buy | Maintains | $54 → $36 | +90.78% | Nov 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $53 → $54 | Strong Buy | Maintains | $53 → $54 | +186.17% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $51 → $53 | Strong Buy | Maintains | $51 → $53 | +180.87% | May 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $46 | Buy | Reiterates | $46 | +143.77% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
104.58M
from 86.67M
Increased by 20.66%
Revenue Next Year
119.19M
from 104.58M
Increased by 13.97%
EPS This Year
0.20
from -1.14
EPS Next Year
0.66
from 0.20
Increased by 225.00%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 107.7M | 124.5M | |
| Avg | 104.6M | 119.2M | |
| Low | 100.5M | 112.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 24.2% | 19.1% | |
| Avg | 20.7% | 14.0% | |
| Low | 15.9% | 7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.21 | 0.68 | |
| Avg | 0.20 | 0.66 | |
| Low | 0.20 | 0.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 234.6% | |
| Avg | - | 225.0% | |
| Low | - | 212.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.